Jeffrey Ravetch V serves as Executive at MABVAX THERAPEUTICS HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Jeffrey Ravetch V has executed 5 insider transactions totaling $157.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 2, 2017 involved exercising options for 1,543 shares valued at $0.
Jeffrey Ravetch V currently holds 3,086 shares of MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Ravetch V has been a net seller of MBVX stock. They have purchased $0 and sold $157.8K worth of shares.
Jeffrey Ravetch V's most recent insider trade was on Apr 2, 2017, when they sold 1,543 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 11,417 |
| $N/A |
| Discretionary |
| Mar 24, 2016 | MBVX | $78.9K | Sale | 131,500 | $0.60 | Discretionary |
| Mar 24, 2016 | MBVX | $78.9K | Sale | 131,500 | $0.60 | Discretionary |
| Apr 4, 2015 | MBVX | $0 | Award | 131,500 | $N/A | Discretionary |